Global Home Healthcare Market 2016-2020

2016-05-09
Price :
Published : May-2016
No. of Pages : 66

Home healthcare refers to a wide range of medical products (include heart rate monitors, blood glucose level indicators, and nebulizers), services, and solutions that provide health monitoring, treatment, and physical support to patients or customers at home. People do not need to visit a hospital or any other healthcare facility to benefit from these offerings; they can be accessed in the comfort of homes. The home healthcare market offers complete solutions that include the product as well as software and support from consultants and physicians.

The analysts forecast Global Home Healthcare Market to grow at a CAGR of 8.85% during the period 2016-2020.

Covered in this report

This report covers the present scenario and the growth prospects of the Global Home Healthcare Market for 2016-2020.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • Europe
  • MEA

The report, Global Home Healthcare Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Johnson & Johnson
  • Omron Healthcare
  • Philips
  • McKesson
  • Roche Holdings

Other prominent vendors

  • A&D Company
  • Abbott
  • Almost Family
  • Apria Healthcare
  • eCaring
  • Fresenius
  • Gentiva Health Services
  • Interim Healthcare
  • Kindred Healthcare
  • Linde Healthcare
  • LJC Group
  • Kinnser Software
  • Rotech Healthcare

Market driver

  • Growing demand for affordable healthcare solutions
  • For a full, detailed list, view our report

Market challenge

  • Complexity in pricing
  • For a full, detailed list, view our report

Market trend

  • Integration of mobile devices with home healthcare systems
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : Technavio
More Reports
Title Price Buy Now

Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H2, 2017

Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H2, 2017" provides an overview of Gastrointestinal Stromal Tumor (GIST) clinical trials scenario. This report provides top line data relating to the clinical trials on Gastrointestinal Stromal Tumor (GIST). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are ......
$2500

Fibrosis Global Clinical Trials Review, H2, 2017

Fibrosis Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Fibrosis Global Clinical Trials Review, H2, 2017" provides an overview of Fibrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Fibrosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are coll......
$2500

Fungemia Global Clinical Trials Review, H2, 2017

Fungemia Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Fungemia Global Clinical Trials Review, H2, 2017" provides an overview of Fungemia clinical trials scenario. This report provides top line data relating to the clinical trials on Fungemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are coll......
$2500

Gastroparesis Global Clinical Trials Review, H2, 2017

Gastroparesis Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Gastroparesis Global Clinical Trials Review, H2, 2017" provides an overview of Gastroparesis clinical trials scenario. This report provides top line data relating to the clinical trials on Gastroparesis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clin......
$2500

Filariasis Global Clinical Trials Review, H2, 2017

Filariasis Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Filariasis Global Clinical Trials Review, H2, 2017" provides an overview of Filariasis clinical trials scenario. This report provides top line data relating to the clinical trials on Filariasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials ......
$2500

Gall Stone Global Clinical Trials Review, H2, 2017

Gall Stone Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Gall Stone Global Clinical Trials Review, H2, 2017" provides an overview of Gall Stone clinical trials scenario. This report provides top line data relating to the clinical trials on Gall Stone. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials ......
$2500

Gaucher Disease Global Clinical Trials Review, H2, 2017

Gaucher Disease Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Gaucher Disease Global Clinical Trials Review, H2, 2017" provides an overview of Gaucher Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Gaucher Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials databa......
$2500

Fistula Global Clinical Trials Review, H2, 2017

Fistula Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Fistula Global Clinical Trials Review, H2, 2017" provides an overview of Fistula clinical trials scenario. This report provides top line data relating to the clinical trials on Fistula. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated......
$2500

Gallbladder Cancer Global Clinical Trials Review, H2, 2017

Gallbladder Cancer Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Gallbladder Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Gallbladder Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Gallbladder Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical t......
$2500

Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2017

Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2017" provides an overview of Pre-Diabetes/Impaired Glucose Tolerance clinical trials scenario. This report provides top line data relating to the clinical trials on Pre-Diabetes/Impaired Glucose Tolerance. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Repo......
$2500